对80岁以上高龄患者应用逆行性胰胆管造影的有效性与安全性研究  

Efficacy and safety of therapeutic endoscopic retrograde cholangiopancreatography in octogenrian

作　　者：卫金歧[1] 吕卫华[1] 

机构地区：[1]中山大学附属第五医院消化科,广东省珠海市519000

出　　处：《中国医药》2010年第2期123-124,共2页China Medicine

基　　金：2006年广东省珠海市科技计划项目（PC20061078）

摘　　要：目的评估≥80岁高龄患者应用逆行性胰胆管造影（ERCP）的有效性和安全性。方法对53例患者进行积极的术前准备，合并有心肺等疾病的患者予以有效的治疗。根据ERCP检查结果制订治疗方案。结果92．45％（49／53）实施了治疗性ERCP。其中36例胆总管结石患者接受了乳头括约肌切开（EST）并成功取出结石，行鼻胆引流管置人（ENBD）术42例，内支架置人术7例。并发症发生率9．43％（5／53），无严重并发症及死亡发生。结论治疗性ERCP对≥80岁高龄患者是安全和有效的，高龄不应成为限制该项技术麻用的禁恩。Objective To evaluate the efficacy and the safety of therapeutic endoscopic retrograde cholangiopancreatography（ERCP） in octogenrian. Methods Complete preparation should be carried out before procedure. The circulative and respiratory diseases should be treated effectively. The treatment was determined according to pa- tient＇s condition after ERCP. Results Therapeutic ERCP were done in 49/53 （92.45%）, 36 common bile duct stones patients underwent endoscopic sphineterotomy（EST）. 42 endoscopic nasobiliary drainage（ENBD） were done. Stents were used in 7 cancer patients. Complications were observed in 9.43 % （5/53） of therapeutic ERCP but no severe complications and death occured. Conclusion Therapeutic ERCP is safe and effective for the treatment of pancreatobiliary diseases in octogenrian.

关 键 词：胰胆道疾病 胰胆管造影 高龄患者 

分 类 号：R575.6[医药卫生—消化系统]